台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效

生華科

(6492)
可現股當沖
  • 股價
    41.70
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    246
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
生華科 (6492)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/21 ~ 2024/04/28     後一日»

券商獲利排行 - 2024/04/21 ~ 2024/04/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.54%330333232040.740.7041.7
  2.14%17.5017.52020040.840.8041.7
  1.59%16.20.815.41725840.840.840.941.7
  1.52%14.2-0.314.51723640.840.840.841.7
  2.96%13.2013.21111040.540.5041.7
  1.17%11.5-0.712.11524940.940.940.841.7
  1.78%9.509.5131304141041.7
  1.79%8.1-0.28.21011140.940.940.741.7
  2.38%7.707.778040.740.74141.7
  2.42%6.906.977040.740.7041.7
  1.89%6.20.2668240.740.740.841.7
  2.14%5.332.226440.940.641.441.7
  2.07%5.10.24.946140.840.740.941.7
  2.48%5.105.155040.740.7041.7
  2.32%4.704.755040.840.841.441.7
  2.26%4.604.655040.840.8041.7
  2.26%4.604.655040.840.8041.7
  2.71%4.404.444040.640.6041.7
  2.09%4.30.14.245140.740.740.741.7
  2.58%4.204.244040.740.7041.7
  0.30%4.12.31.82343240.940.840.941.7
  2.46%40444040.740.7041.7
  1.75%3.62.70.915441.140.841.541.7
  2.21%3.603.644040.840.8041.7
  1.30%3.2-0.33.5561414140.741.7
  2.46%30333040.740.7041.7
  2.42%30333040.740.7041.7
  2.42%30333040.740.7041.7
  2.29%2.802.833040.840.8041.7
  2.25%2.802.833040.840.8041.7
  2.21%2.702.733040.840.8041.7
  1.66%2.7-0.12.834140.740.840.741.7
  0.27%2.7-5.98.512241240.84140.541.7
  2.16%2.702.733040.840.8041.7
  2.16%2.702.733040.840.8041.7
  2.96%2.402.422040.540.5041.7
  2.84%2.302.322040.640.6041.7
  2.71%2.202.222040.640.6041.7
  2.71%2.202.222040.640.6041.7
  2.71%2.202.222040.640.6041.7
  2.71%2.202.222040.640.6041.7
  2.65%2.202.222040.640.6041.7
  2.65%2.202.222040.640.6041.7
  2.46%20222040.740.7041.7
  2.46%20222040.740.7041.7
  2.46%20222040.740.7041.7
  2.46%20222040.740.7041.7
  2.39%1.901.922040.740.7041.7
  2.33%1.901.922040.840.8041.7
  2.27%1.901.922040.840.8041.7

券商虧損排行 - 2024/04/21 ~ 2024/04/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.79%-36.80-36.8-500504104141.7
  -2.56%-26.10-26.1-2502540.7040.741.7
  -2.56%-20.80-20.8-2002040.7040.741.7
  -2.57%-18.80-18.8-1801840.7040.741.7
  -1.74%-14.20.5-14.7-1732040.840.740.841.7
  -1.90%-10.1-0.6-9.5-121134141.540.941.7
  -2.71%-7.70-7.7-70740.6040.641.7
  -2.58%-7.40-7.4-70740.7040.741.7
  -2.46%-70-7-70740.7040.741.7
  -2.08%-60-6-70740.9040.941.7
  -2.86%-5.80-5.8-50540.5040.541.7
  -1.96%-5.60.1-5.7-61740.740.640.741.7
  -2.25%-5.50-5.5-60640.8040.841.7
  -2.46%-50-5-50540.7040.741.7
  -2.46%-50-5-50540.7040.741.7
  -0.61%-4.5-2.6-1.9-2161840.940.940.841.7
  -2.16%-4.40-4.4-50540.8040.841.7
  -2.46%-40-4-40440.7040.741.7
  -2.46%-40-4-40440.7040.741.7
  -1.91%-3.90-3.9-50540.9040.941.7
  -2.39%-3.90-3.9-40440.7040.741.7
  -2.36%-3.90-3.9-40440.7040.741.7
  -2.33%-3.80-3.8-40440.8040.841.7
  -2.96%-3.60-3.6-30340.5040.541.7
  -2.92%-3.60-3.6-30340.5040.541.7
  -1.96%-3.20-3.2-40440.9040.941.7
  -1.86%-3-0.4-2.6-31440.941.340.841.7
  -1.83%-30-3-4044104141.7
  -2.46%-30-3-20340.74140.741.7
  -1.42%-2.90-2.9-32540.740.840.741.7
  -2.33%-2.90-2.9-30340.8040.841.7
  -0.40%-2.81.8-4.6-6111740.940.840.941.7
  -1.35%-2.70.2-2.9-32540.740.640.741.7
  -2.21%-2.70-2.7-30340.8040.841.7
  -2.21%-2.70-2.7-30340.8040.841.7
  -2.00%-2.50-2.5-20340.94140.941.7
  -1.17%-2.4-0.7-1.7-23540.941.140.841.7
  -1.96%-2.40-2.4-30340.9040.941.7
  -2.71%-2.20-2.2-20240.6040.641.7
  -2.71%-2.20-2.2-20240.6040.641.7
  -1.76%-2.2-0.2-2-21340.840.940.741.7
  -1.71%-2.10-2.1-3034104141.7
  -2.58%-2.10-2.1-20240.7040.741.7
  -2.58%-2.10-2.1-20240.7040.741.7
  -2.50%-20-2-20240.7040.741.7
  -2.46%-20-2-20240.7040.741.7
  -2.33%-1.90-1.9-20240.8040.841.7
  -2.33%-1.90-1.9-20240.8040.841.7
  -2.25%-1.80-1.8-20240.8040.841.7
  -2.21%-1.80-1.8-20240.8040.841.7
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音